Since the establishment of Tianjiang Pharmaceutical, the research team has continuously injected more valuable "technology" into traditional Chinese medicine, consolidating Tianjiang Pharmaceutical's leading position in the national Chinese medicine manufacturing industry. At present, the Tianjiang Pharmaceutical Research Institute has a team of nearly 200 people and has established seven research institutes including the Institute of Medicinal Materials, the Institute of Standards, the Institute of R&D Quality Management, the Institute of New Drugs, the Institute of Technology, the Institute of Achievement Transformation and the Institute of Technology Management.
Tianjiang Research Institute has established a whole-process quality standard system to ensure the safety, effectiveness, stability and controllability of traditional Chinese medicine extract granules through research on planting technology of traditional Chinese medicine, research on technology of traditional Chinese medicine formula granules, and research on internal control standards of traditional Chinese medicine extract granules.
In recent years, more than 10 national and provincial R&D platforms have settled in Tianjiang Research Institute, including the National Enterprise Technology Center, the first academician workstation in the industry - Academician Chen Keji Workstation, and the first Chinese Medicine Master Studio - Xuan Guowei Chinese Medicine Master Studio, post-doctoral workstation, Jiangsu Province Chinese Medicine Formula Granule Engineering Technology Center, etc. The continuously strong scientific research strength has become the driving force for the development of the enterprise.
So far, the Tianjiang R&D team has undertaken more than 30 scientific research projects such as the State Administration of Traditional Chinese Medicine, the Ministry of Science and Technology, the Ministry of Industry and Information Technology, and more than 200 self-research projects. Tianjiang Pharmaceutical has 55 authorized patents, and its research results have been recognized as "Excellent Achievements in Modernization of Traditional Chinese Medicine" by the Ministry of Science and Technology.
As a key subsidiary of Sinopharm Group's modern traditional Chinese medicine sector, Tianjiang Pharmaceutical has the responsibility and ability to do a good job in promoting the high-quality development of my country's traditional Chinese medicine industry. At the same time, TCM formula granules with strict standards are helpful for the international market to understand TCM culture. In the future, Tianjiang Pharmaceuticals will always adhere to the research and development concept of "ingenuity inheritance, innovation and leadership", and constantly strive to build the company into a domestic leading and world-class modern Chinese medicine scientific research innovation base and industrialization base. We will continue to contribute to the promotion of traditional Chinese medicine culture and the continuous leadership of the standardization, modernization and internationalization of traditional Chinese medicine!